Sulfonated Hyaluronic Acid‐Based Polymers and Hydrogels Using Thiol‐Ene and Thiol‐Michael Reactions
Macromolecular Bioscience · 2026-04 · 26 (4)
DOI: 10.1002/mabi.202500319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 07.04.2026. Verfasst von Ivo Anton Octave Beeren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Neth…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Hydrogels, Sulfhydryl Compounds, Sulfonic Acids. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Horizon2020, ON/EORS.
Abstract (Originalsprache)
Non‐sulfated polysaccharides like hyaluronic acid (HA) have been widely studied as scaffold material for tissue engineering applications. To mimic the function of sulfated glycosaminoglycan in the matrix, sulfate groups can be grafted. However, here, harsh reaction conditions are required which induce significant backbone degradation. As an alternative, sulfonates (R‐SO 3 − ) have been shown to resemble the function of sulfates yet have not been introduced on polysaccharides. Using a two‐step strategy, we introduced a tunable amount of sulfonate groups on HA, without requiring harsh reaction conditions and organic solvents. By varying the degree of carboxylic acid activation using 4‐(4,6‐dimethoxy‐1,3,5‐triazin‐2‐yl)‐4‐methylmorpholinium chloride (DMTMM), norbornene (NB, 3–18%) or maleimide (MAL, 2–14%) groups were grafted. Subsequently, 3‐mercapto‐1‐propanesulfonate was coupled in high efficiency on the addressable groups via orthogonal thiol‐ene and thiol‐Michael addition. Additionally, we demonstrated the formation of hydrogels using poly(ethylene glycol)‐di‐SH as a crosslinker. However, because of the low crosslinking kinetics, HA‐MAL appeared not useful for application. Simultaneous addition of the crosslinker and MPS to norbornyl‐conjugated HA's in various ratios enabled the formation of hydrogels with tunable stiffness and degree of sulfonate groups. The simple strategy is likely applicable to other commonly used polysaccharides and therefore interesting to the broader tissue engineering community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
- Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
- POLYMAT, University of the Basque Country UPV/EHU, Donostia/San Sebastián, Spain.
- IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
ORCID-Profile: Ivo Anton Octave Beeren, Carlos Mota, Lorenzo Moroni, Matthew Brandon Baker
Förderung
- European Research Council
- Horizon2020
- ON/EORS
Zitieren
APA
Beeren, I. A. O., Dijkstra, P. J., Sanchez, A. A., Ramis, J., Perin, F., Mota, C., Camarero-Espinosa, S., Moroni, L., & Baker, M. B. (2026). Sulfonated Hyaluronic Acid‐Based Polymers and Hydrogels Using Thiol‐Ene and Thiol‐Michael Reactions. Macromolecular Bioscience, 26(4). https://doi.org/10.1002/mabi.202500319
Vancouver
Beeren IAO, Dijkstra PJ, Sanchez AA, Ramis J, Perin F, Mota C, et al. Sulfonated Hyaluronic Acid‐Based Polymers and Hydrogels Using Thiol‐Ene and Thiol‐Michael Reactions. Macromolecular Bioscience. 2026;26(4). doi:10.1002/mabi.202500319
BibTeX
@article{Beeren2026,
author = {Beeren, Ivo Anton Octave and Dijkstra, Pieter Jelle and Sanchez, Ane Albillos and Ramis, Jopeth and Perin, Francesca and Mota, Carlos and Camarero-Espinosa, Sandra and Moroni, Lorenzo and Baker, Matthew Brandon},
title = {Sulfonated Hyaluronic Acid‐Based Polymers and Hydrogels Using Thiol‐Ene and Thiol‐Michael Reactions},
journal = {Macromolecular Bioscience},
year = {2026},
volume = {26},
number = {4},
doi = {10.1002/mabi.202500319}
}
EUVIMED